/Marsh%20%26%20McLennan%20Cos_%2C%20Inc_%20magnified%20logo%20by-%20Casimiro%20PT%20via%20Shutterstock.jpg)
Marsh & McLennan has lagged behind the broader financial sector over the past year, but analysts remain reasonably bullish about the stock’s prospects.
/Willis%20Towers%20Watson%20Public%20Limited%20Co%20Chicago%20tower-by%20FieldIMAGE%20via%20iStock.jpg)
Willis Towers Watson has underperformed the Nasdaq recently, yet analysts remain moderately optimistic about the stock’s prospects.
Insurance Brokers Q4 Earnings: Marsh & McLennan (NYSE:MRSH) is the Best in the Biz
Copart, Huron, Brown & Brown, Marsh & McLennan, and Omnicom Group Shares Are Falling, What You Need To Know
Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today announced that Nick Studer will become President and CEO of Marsh Risk, succeeding...
2 Profitable Stocks to Research Further and 1 We Question
The Board of Directors of Marsh (NYSE: MRSH) today declared a quarterly dividend of $0.900 per share on outstanding common stock, payable on May 15, 2026, to stockholders of record on April 9, 2026....
Mercer, a Marsh business (NYSE: MRSH) and a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people, today...
Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today appointed Peter Harrison as a director, effective immediately. The Company’s...